Earnings Feed
Start Free
Twist Bioscience Corp·4

Feb 17, 4:25 PM ET

Finn Patrick John 4

Research Summary

AI-generated summary

Updated

Twist Bioscience (TWST) President Finn P. John Exercises Options, Sells Shares

What Happened
Finn Patrick John, President and COO of Twist Bioscience (TWST), exercised stock options on Feb 12–13, 2026 to acquire 3,712 shares (strikes $23.33 and $26.66; total cash paid ~$93,967). He also sold 5,250 shares in open-market transactions (3,500 shares on 2/12 at $50.23; 1,750 shares on 2/13 at $50.04) for aggregate proceeds of about $263,360. The Form 4 also records 3,712 shares disposed at $0 in connection with the option exercises (see Key Details).

Key Details

  • Transaction dates: Feb 12–13, 2026.
  • Option exercises (acquired): 1,000 @ $23.33 ($23,330); 1,500 @ $26.66 ($39,990); 500 @ $23.33 ($11,665); 712 @ $26.66 ($18,982). Total cash paid ≈ $93,967.
  • Open-market sales (disposed): 3,500 @ $50.23 ($175,788) on 2/12; 1,750 @ $50.04 ($87,572) on 2/13. Total proceeds ≈ $263,360. Price range reported $50.00–$50.51; F2 notes a weighted average and range.
  • Exercise-related disposals: 3,712 shares listed as disposed at $0 (derivative). These match the number of shares exercised and likely reflect surrender/netting or tax withholding related to the exercises (common reporting treatment).
  • Shares owned after the transactions: not specified in the provided excerpt of the filing.
  • Footnotes of note: F1 — trades were conducted under a previously adopted Rule 10b5-1 trading plan (May 13, 2025). F3/F4 — the options were immediately exercisable with standard vesting schedules described in the filing.
  • Filing timeliness: Form filed Feb 17, 2026 for trades on Feb 12–13; this appears to be after the typical 2-business-day Form 4 deadline (i.e., the filing may be late).

Context
This was an option exercise combined with same-period open-market sales. The matching number of exercised shares and $0 disposals suggests some or all exercised shares were surrendered or netted (or used for tax/settlement), while additional stock was sold from holdings in open market trades. Exercises are not direct bullish purchases unless shares are retained; open-market sales are typically routine or plan-driven—here the trades were executed under a 10b5-1 plan (F1), which formalizes scheduled trades and reduces implication of opportunistic timing.